STAT

STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies

STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapiesWorldPing

After the failure of an experimental drug for Angelman syndrome, experts cautioned that there is still reason to think similar experimental medicines can succeed.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news